South Africa: SA to Lead Major HIV Vaccine Trial

Durban — Achieving AIDS reduction targets and eventually ending the disease by 2030 is taking centre stage at the 21st International AIDS conference, underway in Durban.

The conference has seen the debate on finding an effective HIV preventative vaccine resonate among many delegates. And now it has emerged that South Africa is about to launch a ground breaking AMP study or Antibody Mediated Prevention study soon, the biggest in seven years.

...

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.